VANGUARD GROUP INC

Holdings History for AVADEL PHARMACEUTICALS PLC - Ordinary Shares, nominal value $0.01 per share (AVDL)

Symbol: AVDL
Investment type: Equity / Ordinary Shares, nominal value $0.01 per share
Latest Disclosed Shares Owned: 5,564,259 shares
Security Ownership %: 5.7%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in AVADEL PHARMACEUTICALS PLC Ordinary Shares, nominal value $0.01 per share (AVDL)

29 Jul 2025 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,564,259 shares of AVADEL PHARMACEUTICALS PLC Ordinary Shares, nominal value $0.01 per share (AVDL). This represents 5.7% ownership of the company. This is the first filing by VANGUARD GROUP INC disclosing ownership of AVADEL PHARMACEUTICALS PLC Ordinary Shares, nominal value $0.01 per share (AVDL).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
The Vanguard Group	5.7%		$49,243,692	5,564,259			$8.85	13G	30 Jun 2025	29 Jul 2025, 15:01
The Vanguard Group	5.7%		$49,243,692	5,564,259			$8.85	13G	30 Jun 2025	29 Jul 2025, 15:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$126,386,030	5,864,781	+258,499	+4.6%	$21.55	Q4 2025
30 Sep 2025	0%	+0%	$85,607,927	5,606,282	+42,023	+0.76%	$15.27	Q3 2025
30 Jun 2025	0%	+0%	$49,243,693	5,564,259	+1,659,609	+43%	$8.85	Q2 2025
31 Mar 2025	0%	-0%	$30,573,410	3,904,650	-48,597		$7.83	Q1 2025
31 Dec 2024	0%	+0%	$41,548,626	3,953,247	+90,147	+2.3%	$10.51	Q4 2024
30 Sep 2024	0%	+0%	$50,664,556	3,863,100	+171,737	+4.7%	$13.11	Q3 2024
30 Jun 2024	0%	+0%	$51,900,564	3,691,363	+3,691,363	NEW	$14.06	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.